Call Is Confidential & Toll Free


Genvoya, used as Genvoya fumarate (TAF ), is a nucleotide reverse transcriptase inhibitor and a novel prodrug of tenofovir. It is under development by Gilead Sciences for use in the treatment of HIV infection and chronic hepatitis B. Closely related to the commonly used reverse-transcriptase inhibitor tenofovir disoproxil fumarate (Viread), TAF has greater antiviral activity and better distribution into lymphoid tissues than that agent. Genvoya was approved in the U.S. in November 2015 for use in combination with elvitegravir, cobicistat, and emtricitabine for the treatment of HIV .


Drug: Genvoya
Strength: Cobicistat 150 Mg / Elvitegravir 150 Mg / Emtricit
Pill Imprint: GSI 510
Color: Green
Shape: Capsule-shape

View Images & Details
Disclaimer: We strive to ensure that the content on pilladdictions.com is current and factual at the time it was written. However, because new information and discoveries are always becoming available, we are not making any representations or warranties with respect to this content. Please always rely on the guidance of your physician for information about the drugs you are taking and the impacts they may or may not have on your health.

Questions About Prescription Drug Addiction?

(888) 740-2069

Questions About Prescription Drug Addiction?